Trentmann; Stefan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trentmann; Stefan.The latest application filed is for "tear lipocalin muteins binding il-4 r alpha".

Company Profile

4.12.17

Trentmann; Stefan - Allershausen DE
Trentmann; Stefan - Allerhausen N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tear Lipocalin Muteins Binding Il-4 R Alpha App 20210196788 - HOHLBAUM; Andreas ; et al.	2021-07-01
Tear lipocalin muteins binding IL-4 r alpha Grant 10,898,545 - Hohlbaum , et al. January 26, 2	2021-01-26
Tear Lipocalin Muteins Binding Il-4 R Alpha App 20190240289 - Hohlbaum; Andreas ; et al.	2019-08-08
Tear lipocalin muteins binding IL-4 R alpha Grant 10,232,014 - Hohlbaum , et al.	2019-03-19
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20180311311 - Hohlbaum; Andreas ; et al.	2018-11-01
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Grant 9,950,034 - Hohlbaum , et al. April 24, 2	2018-04-24
Human Neutrophil Gelatinase-associated Lipocalin (hngal) Muteins That Bind Hepcidin And Nucleic Acid Encoding Such App 20170369542 - TRENTMANN; Stefan ; et al.	2017-12-28
Tear Lipocalin Muteins Binding Il-4 R Alpha App 20170340703 - HOHLBAUM; Andreas ; et al.	2017-11-30
Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same Grant 9,751,920 - Matschiner , et al. September 5, 2	2017-09-05
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20170224770 - HOHLBAUM; ANDREAS ; et al.	2017-08-10
Tear lipocalin muteins binding IL-4 R alpha Grant 9,687,524 - Hohlbaum , et al. June 27, 2	2017-06-27
Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation Grant 9,610,356 - Hohlbaum , et al. April 4, 2	2017-04-04
Muteins With Tear Lipocalin Having Affinity To Human C-met Receptor Tyrosine Kinase And Methods For Obtaining The Same App 20160200780 - MATSCHINER; GABRIELE ; et al.	2016-07-14
Novel Lipocalin-mutein Assays For Measuring Hepcidin Concentration App 20150369821 - TRENTMANN; Stefan ; et al.	2015-12-24
Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same Grant 9,212,208 - Matschiner , et al. December 15, 2	2015-12-15
Human Neutrophil Gelatinase-associated Lipocalin (hngal) Muteins That Bind Hepcidin And Nucleic Acid Encoding Such App 20150291675 - TRENTMANN; STEFAN ; et al.	2015-10-15
Tear Lipocalin Muteins Binding Il-4 R Alpha App 20150283207 - HOHLBAUM; Andreas ; et al.	2015-10-08
Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such Grant 9,051,382 - Trentmann , et al. June 9, 2	2015-06-09
Tear lipocalin in muteins binding IL-4 R alpha Grant 8,986,951 - Hohlbaum , et al. March 24, 2	2015-03-24
Methods For Preventing Or Treating Disorders By Increasing Bioavailability Of Iron And Related Pharmaceutical Formulation App 20140323389 - Hohlbaum; Andreas ; et al.	2014-10-30
Binding Proteins For Hepcidin App 20130244955 - Trentmann; Stefan ; et al.	2013-09-19
Tear Lipocalin In Muteins Binding Il-4 R Alpha App 20130085113 - Hohlbaum; Andreas ; et al.	2013-04-04
Muteins With Tear Lipocalin Having Affinity To Human C-met Receptor Tyrosine Kinase And Methods For Obtaining The Same App 20110098211 - Matschiner; Gabriele ; et al.	2011-04-28
In Vivo Imaging Agents For Met Receptor Tyrosine Kinase App 20090274623 - Smith; Clifford L. ; et al.	2009-11-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.